MedPath
NMPA Approval

Mites allergens ALK(503)D.p

国药准字SJ20140015

September 11, 2024

S20140015

Drug Information

屋尘螨变应原制剂

安脱达

注射剂

100,1000,10000,100000 SQ-U/ml

生物制品

September 11, 2024

September 10, 2029

Company Information

Applicant Company

ALK-ABELLO A/S

Boge Alle 6-8, DK-2970 Horsholm, Denmark

Manufacturing Company

ALK-ABELLO A/S

Boge Alle 6-8, DK-2970 Horsholm, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

屋尘螨变应原制剂 - NMPA 批准文号 | MedPath